Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.210 | 1.530 | 0.320 |
Shares | 98.790 | 98.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.178 | 18.475 |
Price to Book | 2.980 | 3.781 |
Price to Sales | 5.249 | 5.454 |
Price to Cash Flow | 12.610 | 13.630 |
Dividend Yield | 0.546 | 0.505 |
5 Years Earnings Growth | 37.504 | 21.243 |
Number of long holdings: 50
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.34 | 438.40 | -0.71% | |
Alnylam | US02043Q1076 | 6.68 | 277.16 | +1.16% | |
Neurocrine | US64125C1099 | 5.37 | 153.29 | +1.73% | |
Guardant Health | US40131M1099 | 4.39 | 49.94 | +4.81% | |
Amgen | US0311621009 | 4.25 | 284.02 | +0.83% | |
Regeneron Pharma | US75886F1075 | 4.23 | 683.08 | -0.61% | |
Moderna | US60770K1079 | 3.85 | 41.04 | +0.79% | |
AbbVie | US00287Y1091 | 3.78 | 175.65 | +0.22% | |
Denali Therapeutics | US24823R1059 | 3.67 | 23.58 | +0.73% | |
Roivant Sciences Ltd Ordinary Shares | - | 3.57 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.55B | 0.71 | 0.67 | - | ||
LU1300848345 | 6.55B | 0.98 | 0.97 | - | ||
LU1323611266 | 4.13B | 4.34 | 0.23 | - | ||
LU1520716801 | 4.13B | 7.31 | 2.63 | - | ||
UBS lux Eq SICAV USAGrwth USD Q Acc | 2.96B | 31.92 | 7.74 | 14.69 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review